Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Humira
Active Ingredient: Adalimumab 10mg
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
   
Product: Humira
Active Ingredient: Adalimumab 20mg
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
   
Product: Humira (20mg/0.2mL)
Active Ingredient: Adalimumab 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
   
Product: Humira (40mg/0.4mL)
Active Ingredient: Adalimumab 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
AbbVie Biotechnology Limited, Barceloneta, Puerto Rico
   
Product: Humira (40mg/0.8mL)
Active Ingredient: Adalimumab 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
   
Product: Humira (80mg/0.8mL)
Active Ingredient: Adalimumab 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
AbbVie Biotechnology Limited, Barceloneta, Puerto Rico
   
Product: Humira (40mg/0.4mL Pen)
Active Ingredient: Adalimumab 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
AbbVie Biotechnology Limited, Barceloneta, Puerto Rico
   
Product: Humira (40mg/0.8mL Pen)
Active Ingredient: Adalimumab 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Aesica Queenborough Limited, Queenborough, United Kingdom
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
   
Product: Humira (80mg/0.8mL Pen)
Active Ingredient: Adalimumab 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AbbVie Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
AbbVie Biotechnology Limited, Barceloneta, Puerto Rico
   
Product: Miacalcic
Active Ingredient: Salcatonin 100IU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Emerge Health New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
   
Product: Nizoral 1%
Active Ingredient: Ketoconazole 10mg/mL
Dosage Form: Shampoo
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: Janssen Pharmaceutica NV, Beerse, Belgium


Dated this 15th day of June 2020.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).